Clinical Trials Logo

Clinical Trial Summary

The aim of our study is to determine whether the use of a tourniquet during TKA would affect total measured blood loss , operation time, postoperative complications; hemoglobin concentration; limb swelling and postoperative pain.


Clinical Trial Description

Tourniquets are widely used in total knee arthroplasty (TKA) . TKA has been reported to be associated with significant blood loss which at times necessitates transfusion. Although the tourniquet is widely used by orthopedic surgeons, its role is controversial . Several studies have shown that using a tourniquet in TKA could reduce the total blood loss, while results from others indicated the opposite . Therefore the relationship between the use of a tourniquet and the total blood loss of patients undergoing TKA is still unclear. The use of a tourniquet is believed to be effective for decreasing intraoperative blood loss and creating a bloodless surgical field, which theoretically would facilitate the cementing technique and other surgical procedures. However, reactive blood flow reaches its peak within five minutes after the tourniquet has been released Complications reported as a consequence of tourniquet application are skin injury [skin abrasions, blisters, breaks , pressure necrosis], nerve injury, post tourniquet syndrome, Deep venous thrombosis, Postoperative pain, wound healing disorders and early infections ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05144425
Study type Interventional
Source Assiut University
Contact Mohamed Elbasel Abdel Raheem, Bachelor
Phone 01091673453
Email dmbheba21@gmail.com
Status Not yet recruiting
Phase N/A
Start date December 10, 2021
Completion date December 2022

See also
  Status Clinical Trial Phase
Completed NCT02427711 - Reduced Total Blood Loss and Blood Transfusion in Non-Septic Revision Knee Arthroplasty Using a Bipolar Sealer N/A
Not yet recruiting NCT03310060 - Reducing Blood Loss Using Tisseel in TKA Phase 4
Recruiting NCT05504577 - Kaolin-based Hemostatic Gauze in Total Knee Arthroplasty Phase 4
Recruiting NCT04855877 - Oral Administration of Tranexamic Acid in Anterior Cruciate Ligament Surgery Reduce Postoperative Haemarthrosis Phase 4
Completed NCT02393300 - Comparison of Topical Versus Intravenous Tranexamic Acid in TKA Phase 3
Completed NCT04691362 - Noninferiority Oral Tranexamic Acid vs Intravenous Administration in Total Hip Arthroplasty Phase 4